3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
NIH
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
11
Breast
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
550
Head and Neck Neoplasms
490
Carcinoma, Non-Small-Cell Lung
338
Melanoma
217
Colorectal Neoplasms
206
Ovarian Neoplasms
174
Neoplasms
171
Breast Neoplasms
168
Stomach Neoplasms
141
Carcinoma, Renal Cell
133
Uterine Cervical Neoplasms
129
Neoplasm Metastasis
129
Triple Negative Breast Neoplasms
125
Lung Neoplasms
118
Pancreatic Neoplasms
117
Esophageal Neoplasms
107
Thyroid Neoplasms
95
Endometrial Neoplasms
93
Urinary Bladder Neoplasms
92
Prostatic Neoplasms
88
Sarcoma
81
Carcinoma, Squamous Cell
81
Carcinoma, Transitional Cell
75
Small Cell Lung Carcinoma
74
Carcinoma, Hepatocellular
65
Recurrence
53
Nasopharyngeal Carcinoma
52
Carcinoma
47
Colonic Neoplasms
46
Cholangiocarcinoma
43
Interventions
pembrolizumab
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Chordoma
×
Head & Neck
×
Clear all
NCT04670679
2026-03-25
FLAGSHP-1
Erasca, Inc.
Phase 1
Active not recruiting
90 enrolled